Barclays shrinks investment bank

Barclays is still struggling with their investment banking arms following another round of disappointing results.

The latest results from Britain's banks have triggered the usual row over bonuses and yet more "one-off" charges for various scandals but also some good news.

Lloyds managed a pre-tax profit of £1.8bn last year and announced its first dividend since its £20bn state bailout in 2008. Barclays saw a 12% increase in underlying profits to £5.5bn last year.

However, after a £750m provision for possible fines relating to forex-market rigging, and other one-off costs, the bank registered a small net loss. And both Barclays and RBS are still struggling with their investment banking arms.

What the commentators said

"Financially, Jenkins is justified in saying the bank is healthier than it has been since the crisis." But pay per banker in the investment bank division has risen now that 200 staff have been cut. And the bills for misconduct and alleged fraud "just keep on rising".

Only more cuts will ensure that the investment bank produces returns to beat its cost of capital, said Allister Heath. This means Barclays has reached a "turning point". For the past 31 years, it has "consumed a vast amount of capital" trying to build a world-class investment bank.

But despite "coming tantalisingly close", it hasn't succeeded in building a viable alternative to Goldman Sachs or JP Morgan. RBS is also finding it too expensive, added The Guardian's Jill Treanor, so it's now slimming down to a presence in 13 countries from 51 in 2009.

There will come a time, warned Chirantan Barua of Bernstein, when "we need liquidity in this country and we won't have a British broker-dealer".

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Inflation is now at its highest since 1982 – is this the peak?
Inflation

Inflation is now at its highest since 1982 – is this the peak?

At 9%, UK inflation is at its highest for 40 years – and it’s not going anywhere soon, says John Stepek. That means you need to be much more active a…
18 May 2022